Abstract Alcohol dehydrogenases (ADHs) are applied in industrial synthetic chemistry for the production of optically active secondary alcohols. However, the substrate spectrum of many ADHs is narrow, and few, for example, are suitable for the reduction of prochiral ketones in which the carbonyl group is bounded by two bulky and/or hydrophobic groups; so-called 'bulky-bulky' ketones. Recently two ADHs, RasADH from Ralstonia sp. DSM 6428, and SyADH from Sphingobium yanoikuyae DSM 6900, have been described, which are distinguished by their ability to accept bulky-bulky ketones as substrates. In order to examine the molecular basis of the recognition of these substrates the structures of the native and NADPH complex of RasADH, and the NADPH complex of SyADH have been determined and refined to resolutions of 1.5, 2.9 and 2.5 Å , respectively. The structures reveal hydrophobic active site tunnels near the surface of the enzymes that are well-suited to the recognition of large hydrophobic substrates, as determined by modelling of the bulky-bulky substrate n-pentyl phenyl ketone. The structures also reveal the bases for NADPH specificity and (S)-stereoselectivity in each of the biocatalysts for n-pentyl phenyl ketone and related substrates.
Introduction
Alcohol dehydrogenases (ADHs) have been employed for many years in both academic and industrial groups for the asymmetric reduction of prochiral carbonyl groups to optically active secondary alcohols [8, 25] . The natural diversity of ADHs has ensured that enzymes encompassing a broad range of catalytic characteristics have been made available for applications. Hence there are ADHs that offer (R)- [31] or (S)- [13] selectivity, thermostability [9, 22] and an impressive tolerance to organic solvents that allows the enzymes to be used in the presence of high substrate concentration [13] or even neat substrate itself [11] . One such niche application of ADHs is served by a subgroup of these enzymes that transforms prochiral ketones that feature large hydrophobic groups on either side of the carbonyl group; 'bulky-bulky' ketones.
As part of a culture collection screening programme, Kroutil and co-workers [18] described the cloning, expression and application of an ADH from Ralstonia sp. DSM 6428, which was able to accept these bulky-bulky ketones as substrates. The Ralstonia ADH (RasADH from hereon) enzyme was applied to the reduction of n-butyl phenyl ketone and n-pentyl phenyl ketone 1 with (S)-enantioselectivity and with enantiomeric excesses (e.e.s) of up to[99 % ( Fig. 1) [18] . The excellent enantioselectivity was also extended to bulky-small ketones such as acetophenone. RasADH has subsequently been characterised in some detail by one of our groups [16] . The enzyme was reported to be of the short chain dehydrogenase (SDR) family, with a subunit molecular weight of 26.7 kDa (249 amino acids) and it was suggested that three subunits of the enzyme associated to form a trimer in solution. RasADH exhibited a broad pH optimum for the reductive transformation of benzaldehyde and had a half-life of 80 h at 25°C. The stability of the enzyme could be augmented by the addition of calcium ions. RasADH was subsequently also applied to the reduction of a-hydroxy ketones [15] and in the dynamic kinetic resolution (DKR) of a-alkyl-b-keto esters such as 3 ( Fig. 1) to give (2S, 3S)-products of type 4 [3] .
Further screening of microbial culture collections for the reduction of bulky-bulky ketones revealed a strain of Sphingobium yanoikuyae DSM 6900 that was also able to reduce n-pentyl phenyl ketone 1 to the (S)-alcohol 2 in up to 97 % e.e. [19] . This short chain dehydrogenase, named SyADH, was isolated and the relevant gene cloned and expressed, and subsequently used for the non-selective oxidation of some small prochiral alcohols [20] . Like RasADH, SyADH has also recently been employed in the DKR of a-alkyl-b-keto esters such as 5 [3] , in this case to give (2R, 3S)-diol products 6 with excellent d.e.s and e.e.s Ralstonia ADH and SyADH therefore present distinctly useful biocatalysts as they catalyse the transformation of sterically challenging substrates and with, in some cases, complementary stereo-and diastereo-selectivities to established ADHs. In the case of each of these enzymes, knowledge of their three-dimensional structure would not only provide information for the first time on the determinants of bulk-bulky ketone recognition in such ADHs, but also serve to inform the engineering of other ADHs for transformation of those substrates, or for the expanded substrate specificity of RasADH and SyADH themselves. In this report, we present the X-ray crystal structures of the apo-and NADPH-complex of RasADH at 1.5 and 2.9 Å resolution respectively, and also the structure of the NADPH complex of SyADH at 2.5 Å resolution. These structures reveal the hydrophobic characteristics of the active site(s) that allow accommodation of large hydrophobic substrates, and also shed light on the determinants of cofactor specificity in these 'bulky-bulky' ADH enzymes.
Results and Discussion

Structure of RasADH
Ralstonia ADH was expressed from a strain of E. coli BL21 (DE3) that had been transformed with the gene encoding RasADH ligated into the pET-YSBLIC-3C vector [1] . After purification using nickel affinity and gel filtration chromatography, the pure protein was initially concentrated to 8 mg mL -1 . During this process problems with precipitation were encountered, but these were successfully addressed through the inclusion of Ca 2? ions, 500 mM sodium chloride and glycerol in the cell resuspension and protein purification buffers (see ''Sect. 6''). Gel filtration studies on the protein derived in this way were suggestive of a tetramer of RasADH monomers in solution, rather than the trimer suggested by earlier studies [16] .
Crystals of RasADH were obtained in two forms, each of which was soaked with 10 mM NADPH before testing diffraction quality. It was found that the first form diffracted to a resolution of 1.5 Å with a C2 1 space group. Data collection and refinement statistics can be found in Table 1 . The structure of RasADH was solved by molecular replacement using a monomer of a 'probable dehydrogenase protein' from Rhizobium etli CFN42 (55 % sequence identity with RasADH; PDB code 4FGS) as a model. In the structure solution there were four monomers A-D in the asymmetric unit, which made up a tetramer (Fig. 2a) , a quaternary association common to some other short-chain ADHs such as the carbonyl reductase from Candida parapsilosis (PDB code 3CTM, [40] ) and levodione reductase from Corynebacterium aquaticum (1IY8, [33] ).
Each monomer of RasADH (Fig. 2b) was made up of a classical Rossman fold with a central b-sheet composed of seven b-strands: b1 (residues 8-13); b2 (33-37); b3 (54-58); b4 (83-87); b5 (131-135); b6 (174-180) and b7 (239-242). The b-sheet was surrounded by six alpha helices: a1 (residues 17-30); a2 (40-50); a3 (64-77); a 4 Numbers in brackets refer to data for highest resolution shells surrounded by six helices, four of which, a3, a4, a5 and a6. Helix a6, which was absent in the apo-enzyme structure, appears to act as a lid to the active site, closing over the NADPH molecule when cofactor is bound. The N and C termini of the apo-enzyme monomer are also indicated. The cofactor NADPH is shown in cylinder format with carbon atoms shown in grey (101-126); a5 (148-168) and a7 (217-228). A further helix, the sixth in sequence order a6 (195-208, as revealed by the NADPH complex structure-vide infra), was largely missing from the density in the apo structure of RasADH. This helix was part of a sequence of residues in the region of Thr185 to Phe205 that in each subunit could not be modelled (although residues Glu200 to Lys204 were present in subunit 'C'). A possible role for this helix is discussed below. Notwithstanding helix a6, the overall fold of the RasADH monomer ( Fig. 2b ) is well-conserved amongst SDR structures; a superimposition of the 'A'-chain of RasADH with that of a monomer of 4FGS gave an r.m.sd. of 0.71 Å over 240 Ca atoms. The RasADH monomer is most similar to 4FGS and a putative oxidoreductase protein from Sinorhizobium meliloti 1021, (PDB code 4ESO; with 41 % sequence identity to RasADH), as determined by analysis using the DALI server [10] , with r.m.s.d values for the latter structure 1.4 Å . over 250 residues. In this first, higher resolution, structure of RasADH no residual density in the omit map corresponding to the NADP(H) cofactor could be observed in the putative active site of the enzyme. A monomer of RasADH (for example, subunit 'A') closely associates with its neighbours 'C' and 'B', and to a lesser extent, 'D', to form the tetramer. Subunit 'A' makes a contact surface area of 1,540 Å 2 with subunit 'C', as calculated using PISA [14] , with interactions dominated by the reciprocal association of helices a7, including stacking interactions between Phe226 residues of each subunit, and strands b7, which are largely governed by hydrophobic side-chain interactions. 'A' also closely interacts with subunit 'B', with a calculated shared interface of 1,670 Å 2 . This pair of monomers interacts most closely through reciprocal interactions between helices a4 and a5, including the indole nitrogen of Trp164 of 'A' with the carboxylate side chain of 'B' Asp148 and a salt bridge between the side-chains of 'A' Asp105 and 'B' Arg 113.
The other crystal form of RasADH diffracted more poorly, to a resolution of 2.9 Å , and in the same C2 1 space group as the apo-enzyme. Using the monomer of the apostructure as a model, the structure solution in this instance yielded six monomers in the asymmetric unit, representing one full tetramer and one half-tetramer. In this case, each monomer featured extensive density in the omit map in the active site that was representative of the cofactor NADPH at full occupancy. In addition, density for the helix a6 in the region of Thr185 to Phe205 was now largely complete, and could be modelled, save for one or two residues in the region of Val191. Chain 'F' was complete, however. The loop density in the NADPH complex confirmed that the loop appears to act as lid for the active site, closing over the cofactor in the holo-form of the enzyme (Fig. 2b ).
Structure of SyADH
SyADH was also subcloned into the pET-YSBLIC-3C vector, and was again expressed well in the soluble fraction of the BL21 (DE3) strain of E. coli. In this case however, gel filtration analysis suggested that SyADH was predominantly a dimer in solution. Crystallisation of SyADH followed cleavage of the hexahistidine tag as described in the ''Sect. 6''. Crystals were of the P2 1 space group. The structure was solved using the programme BALBES [21] , which selected a monomer of the NADPH-dependent blue fluorescent protein from Vibrio vulificus (3P19; 25 % sequence identity with SyADH) as a model. The solution featured five dimer pairs in the asymmetric unit (Fig. 3a) .
The monomer of SyADH (Subunit 'A' will serve as the model for the description below), again features the characteristic Rossman-type fold, again featuring a central Fig. 3 Structure of SyADH. a The asymmetric unit contains ten monomers that constitute five dimers shown in ribbon format and coloured by chain. b Each dimer consists of two monomers, coloured green and coral, each of which exhibits the Rossman (ab) 8 fold, with eight helices (numbered a1-4 and a6-8 for the coral monomer; a5 is obscured) forming the central bundle and a ninth helix a9 that associates closely with the neighbouring monomer. The N and C termini of the coral monomer are also indicated. The cofactor NADPH is shown in cylinder format with carbon atoms shown in grey A last helix, a8, stretching from residues 234-238, is at the C-terminus of the protein and participates in pronounced monomer-monomer ('A'/'B') interactions, helping to form the dimer (Fig. 3b) . Electron density allowed the modelling of residues Thr3 or Leu 4 through Tyr258 in all subunits, with only residue Asn199 not modeled in subunits 'I' and 'J', owing to poor electron density. [34] The overall structural fold of the monomer of SyADH was very similar to that of 2JAH, save for a loop region Phe218-Leu223 between a7 and b7 in SyADH which was longer in 2JAH (Ala227-Val236). Monomer 'A' was calculated to form an interface of 3,700 Å 2 with its dimer partner, subunit 'B', as calculated using PISA [14] . The dimer is stabilised by reciprocal interactions between residues in helices a8, including a salt bridge between the side-chain of residues Asp248 and Arg234 in each subunit, but also reciprocal interactions between a4 and a5, which are structurally homologous with helices a4 and a5 in RasADH, described above.
The Substrate Binding Sites
The active site of RasADH is a hydrophobic tunnel that is formed at the top of the central b-sheet of the Rossman fold as seen in Figs. 2b, 4a , and is partially covered by helix a6 in the NADPH-complex structure. The nicotinamide ring of NADPH sits at the base of this tunnel, lined by residues Tyr150 (the likely proton donor to a nascent alcohol in the reductive ADH-catalysed reaction [6] ), Ser137, Phe205, Leu144, Leu142, Leu201, Val138, Ile91, His147 and Gln191. The strict specificity for the phosphorylated cofactor NADPH is governed by interactions of adjacent arginine residues Arg38 and Arg39 and Asn15, with Arg38 also participating in p-stacking interactions with the adenine ring. The interactions with the phosphate explain the preference of RasADH for NADPH over the non-phosphorylated cofactor NADH.
The active site tunnel in SyADH (Fig. 4b) is situated between two loops formed by Gly195-Val204 and Phe144-Met150, the former in place of helix a6 in RasADH. The nicotinamide ring again occupies the base of the tunnel, the lining of which shares significant homology with RasADH, with probable proton donor Tyr153 (Ras-ADH-Tyr150), Ser140 (Ser137), Met150 (His147),and Val141 (Val138), conserved in respect of steric bulk, but with three larger hydrophobic residues from RasADH replaced by alanine: Ala92 (equivalent to RasADH Ile91) and Ala145 (Leu142) and Ala194 (Gln191), suggestive, at least superficially, of a greater active site volume in SyADH overall. Additional steric bulk is provided in the active site by Trp191 (Ile188) and Phe148 (Leu144). The 2 0 -ribose phosphate group of NADPH is less constrained in SyADH than in RasADH; Arg36 mirrors the location and function of RasADHArg38, but RasADH-Arg39 is not present and is replaced by an aspartate (Asp37) that points away from the phosphate binding site. Ser13 replaces RasADH Gln15 in the other direct interaction with phosphate. The side-chain of an additional arginine, Arg40, which is not present in RasADH is close to the phosphate in SyADH, but, with both terminal N-atoms of the side chain at 3.6 and 3.8 Å from the phosphate oxygen, too far away to suggest a major role in phosphate binding.
The nicotinamide rings of the NADPH cofactors in each case are presented to the active site cavity. The C4 atom of the nicotinamide ring, from which hydride will be delivered to the substrate carbonyl, is in each case 4.2 Å (RasADH) or 4.3 Å (SyADH) from the phenolic hydroxyl of the tyrosine proton donor. In SyADH, the region extending from the space between the nicotinamide C4 and the phenolic hydroxyl of Tyr153, and out into the hydrophobic cavity, contained electron density although no obvious ligands that featured in the crystallization conditions could be modelled.
Modelling Bulky-Bulky Ketones in the Active Sites
Ralstonia ADH and SyADH are distinctive in their ability to reduce ketones in which the prochiral carbonyl group is bounded on either side by hydrophobic groups, such as n-pentyl phenyl ketone 1, which is transformed by each enzyme into the (S)-alcohol with excellent enantiomeric excess, thus exhibiting a Prelog selectivity [29] . With the structures of the enzymes in hand, it was now possible to model the structure of 1 into their active sites, in the knowledge that, given the known (S)-stereospecificity of the enzymes with this substrate, only the re-face of the prochiral ketone would be presented to the C4-nicotinamide atom that delivers hydride, and also that the carbonyl group must be situated within H-bonding distance of the relevant conserved serines (Ser137 in RasADH and S140 in SyADH) and tyrosine proton donors (Tyr150 in RasADH and Tyr153 in SyADH) that are involved in catalysis [6] . 1 was modelled into the active sites of RasADH and SyADH using the programme AUTODOCK-VINA [35] applying a procedure described in the ''Sect. 6''. A comparison of these models is shown in Fig. 5 .
In the model of SyADH with substrate 1, the hydrophobic tunnel can be described in terms of a proximal region nearer the surface of the enzyme, in which the phenyl ring is bound, and a distal region towards the enzyme interior, which binds the alkyl chain. The re-face of the carbonyl in 1 is situated against the nicotinamide ring of NADPH, with the C=O oxygen positioned between the side chains of putative proton donor Tyr153 and Ser140 (Fig. 5a) . As a consequence, the phenyl ring is accommodated in the proximal region of the tunnel, bounded by hydrophobic residues Val141, Ala184, Leu201 and Phe148. The pendant n-pentyl group penetrates the distal region of the tunnel and is bounded by further hydrophobic residues Trp191, Ile190, Ala92 and Met150. In RasADH, the requisite interactions of the carbonyl group with the C4 of NADPH and the side chains of Tyr150 and Ser137 are still observed, but the phenyl ring of the substrate is pressed further into the active site in relation to the SyADH model complex, as a result of steric repulsion by residue Phe205, which is part of the 'lid' helix a6 (Fig. 5b) . In the distal region of the hydrophobic tunnel, penetration of the npentyl chain is prevented by Gln191 and is displaced into the region of the active site occupied by Ile188, which would not be permitted in SyADH because of the presence of bulky Trp191 (seen behind the substrate in Fig. 5a ). The alkyl chain now makes favourable hydrophobic interactions in this position with Phe205 and Ile188 (seen behind the substrate in Fig. 5b ). The models suggest that although each accepts 1, SyADH is better suited to accommodate the substrate. The models are useful in revealing the hydrophobic characteristics of the active sites that permit binding of hydrophobic substrates but also the distinctive substrate ranges of SyADH and RasADH. The model suggest that while the flexible alkyl chain of 1 can be accommodated in the distal region of hydrophobic tunnel through contortion in RasADH, less flexible substituents, such as aromatics, would not be accommodated. This is supported by substrate specificity studies [16] , which show that compounds such as benzoin are poor substrates for RasADH. For SyADH, however, the larger distal portion of the hydrophobic tunnel may allow for the accommodation of such bulky groups. The large capacity of the hydrophobic tunnel of SyADH also suggests a basis for its non-selectivity towards smaller prochiral ketones such as acetophenone [20] with space available for these substrates to be accommodated in such a way that presents the si-or the re-face of the carbonyl group to the NADPH hydride at C4 of the cofactor nicotinamide ring. Interestingly, from Fig. 5 the models suggest that, in both cases, NADPH provides its pro-S hydride to attack the re-face of the carbonyl moiety of n-pentyl phenyl ketone, suggesting that the reaction proceeds by the 'E4 pathway' [2] . Whilst the confirmation of pro-S hydride transfer in RasADH and SyADH awaits analysis using experiments with C4-deuterated cofactors, the structural observation is in agreement with the observed stereospecificity of hydride delivery by other short chain ADHs with Prelog selectivity [27, 28] . Other ADHs of Prelog selectivity such as yeast [YADH, 38] , horse liver [HLADH, 7] , Rhodococcus erythropolis [39] , or Thermoanaerobacter ethanolicus [26] ADHs, supply the NADPH pro-R hydride, thus following the E3 pathway [2] , but in these cases the enzymes are of the zinc-dependent Medium Chain Reductase (MDR) family, in which the opposite face of the nicotinamide ring (of NADH in these cases) is presented to the active site, through rotation around the bond between the nicotinamide ring and the ribose, relative to the conformation observed in the SDR, and as seen in PDB structures 2HCY (YADH, [30] ) and 1LDE (HLADH).
Conclusion
The structures of RasADH and SyADH have revealed the structural basis for the recognition of bulky-bulky ketones in a hydrophobic tunnel near the surface of the enzymes. The structures of enzymes with potential use in biocatalytic applications can be valuable in identifying active site determinants of substrate specificity and enantioselectivity that may inform rational engineering, or randomised mutagenesis at targeted residues, for improved or altered specificity.
Experimental Section
Gene Cloning, Expression and Protein Purification
The genes encoding RasADH and SyADH were obtained from the laboratory of Professor Wolfgang Kroutil, University of Graz, Austria. Each gene was sub-cloned into the pET-YSBLIC-3C vector in York. This vector equips each expressed gene product with an N-terminal hexa-histidine tag. RasADH was amplified by PCR from the template plasmid using the following primers: 5 0 -CCAGGGACCA GCAATGTATCGTCTGCTGAATAAAACCGCAGTTAT TACCG -3 0 (Forward) and 5 0 -GAGGAGAAGGCGCGTT ATTAAACCTGGGTCAGACCACCATCAACAAACAG -3 0 (Reverse). SyADH was amplified using primers 5 0 -CC Following agarose gel analysis of the PCR products, the relevant bands were eluted from the gels using a PCR Cleanup kit Ò (Qiagen). The genes were then sub-cloned into the pET-YSBL-LIC-3C vector using previously published techniques [1] . The resultant plasmids were then used to transform E. coli XL1-Blue cells (Novagen), yielding colonies which in turn gave plasmids using standard miniprep procedures that were sequenced to confirm the identity and sequence of the genes.
The recombinant vector(s) containing the RasADH and SyADH genes were used to transform E. coli BL21 (DE3) cells using 30 lg mL -1 kanamycin as antibiotic marker on Luria-Bertani (LB) agar. Single colonies from agar plate grown overnight were used to inoculate 5 mL cultures of LB broth, which were then grown overnight at 37°C with shaking at 180 rpm. The starter cultures served as inocula for a 1 L cultures of LB broth in which cells were grown until the optical density (OD 600 ) had reached a value of 0.8. Expression of either RasADH or SyADH were then induced by the addition of 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG). The cultures were then incubated at 18°C in an orbital shaker at 180 rpm for approximately 18 h. The cells were harvested by centrifugation for 15 min at 4,225 g in a Sorvall GS3 rotor in a Sorvall RC5B Plus centrifuge. At this point, considerations specific to each protein applied and purification strategies diverged.
For RasADH, cell pellets were resuspended in 20 mL of 50 mM Tris-HCl buffer pH 7.5 containing 500 mM NaCl, 20 mM imidazole, 1 mM CaCl 2 and 10 % glycerol (v/v) (buffer 'A') per 1 L of cell culture. The cell suspensions were then sonicated for 10 9 45 s bursts at 4°C with 30 s intervals. The soluble and insoluble fractions were separated by centrifugation for 30 min at 26,892 g in a Sorvall SS34 rotor. The crude cell lysate from 1L cell culture was loaded onto a 5 mL HisTrap FF crude column (GE Healthcare), which was then washed with buffer 'A') and then the protein eluted with a linear gradient of 20-300 mM imidazole over 20 column volumes at a flow rate of 2.5 mL min -1 . Fractions containing RasADH were combined and concentrated using a 10 kDa cut-off Centricon Ò filter membrane. The concentrated RasADH was then loaded onto a pre-equilibrated S75 Superdex TM 16/60 gel filtration column, which was then eluted with 120 mL of buffer 'A' without imidazole, using a flow rate of 1 mL min -1 . Fractions containing pure RasADH, as determined by SDS-PAGE analysis were combined and stored at 4°C. For SyADH, an equivalent procedure was employed using, in place of buffer 'A', a 50 mM Tris-HCl buffer containing 300 mM NaCl and 20 mM imidazole only (buffer 'B'). All subsequent procedures were equivalent to the strategy employed for RasADH, with purification performed using Ni-NTA chromatography followed by gel filtration. In the case of SyADH, prior to crystallisation, the histidine tag was cleaved using C3 protease using a procedure described previously [1] .
Protein Crystallisation
Crystallization conditions for both enzymes were determined using commercially available screens in the sittingdrop format in 96-well plates using 300 nL drops (150 nL protein plus 150 nL precipitant solution). Positive hits were scaled up in 24 well Linbro dishes using the hanging-drop method of crystallisation, with crystallisation drops containing 1 lL of protein solution and 1 lL of precipitant reservoir. For the apo-RasADH, the best crystals were obtained in 0. Crystals were tested for diffraction using a Rigaku Micromax-007HF fitted with Osmic multilayer optics and a Marresearch MAR345 imaging plate detector. Those crystals that diffracted to greater than 3 Å resolution were retained for full dataset collection at the synchrotron. Complete datasets for the apo-RasADH and its NADH complex, and the SyADH complex with NADPH were collected on beamlines I04, I02 and I04 respectively, at the Diamond Light Source, Didcot, Oxfordshire, UK. Data were processed and integrated using XDS [12] and scaled using SCALA [5] as part of the Xia2 processing system [37] . Data collection statistics are given in structure of the apo-RasADH was solved using MOLREP [36] , using a monomer of structure PDB code 4FGS as a search model. The solution contained four molecules in the asymmetric unit, representing one tetramer. The structure of the RasADH NADPH complex was then solved using the monomer of the apo-RasADH. The structure of SyADH was solved using the programme BALBES [21] , which selected a monomer of the PDB code structure 3P19 as a model. The solution contained five dimers in the asymmetric unit. All structures were built and refined using iterative cycles of Coot [4] and REFMAC [24] employing local NCS restraints. For NADPH complexes of both RasADH and SyADH, the omit maps, after building and refinement of the proteins, revealed residual density at the active sites, which could in each case be successfuly modelled and refined as NADPH. [17] . Refinement statistics are presented in Table 1 . The Ramachandran plot for apoRasADH showed 97.8 % of residues to be situated in the most favoured regions, 1.6 % in additional allowed and 0.5 % outlier residues. For the Ras-ADH-NADPH complex, the corresponding values were 95.3, 4.6 and 0.1 % respectively. For the SyADH-NADPH complex, the corresponding values were 99.0 and 1 % with no residues in outlier regions. Coordinates and structure factors for apoRasADH Ras-NADPH and SyADH-NADPH have been deposited in the Protein Data Bank with the accession codes 4bmn, 4bms and 4bmv respectively.
Docking
Automated docking was performed using AUTODOCK VINA 1.1.2 [2] . Structures for RasADH, SyADH were prepared using AUTODOCK utility scripts. Coordinates for substrate 1 were prepared using PRODRG [32] . A monomer model was used for RasADH and a dimer model was used for SyADH with the appropriate pdbqt files prepared in AUTODOCK Tools. The active site of RasADH and SyADH was contained in a grid of 20 9 30 9 20 and 24 9 18 9 14 respectively with 0.375 Å spacing, centred around the catalytic centre which was generated using AutoGrid in the AUTODOCK Tools interface. The number of runs for genetic algorithm was set to 10 and the rest of the docking parameters were set to default parameters. The dockings were performed by VINA, therefore the posed dockings were below 2 Å rmsd. The results generated by VINA were visualised in AUTODOCK Tools 1.5.6 where the ligand conformations were assessed upon lowest VINA energy, but also the following criteria: The known mechanisms of shortchain ADHs [6] and experimentally-determined enantioselectivity of both RasAH and SyADH for ketone 1 dictated that only poses in which the carbonyl of 1 was observed to make appropriate interactions with the phenolic hydroxyl of the catalytic tyrosine residue (Tyr150 or Tyr153 for RasADH or SyADH respectively); the conserved active site serine [6] (Ser137 or Ser140 for RasADH or SyADH respectively) and which presented the (re)-face of the carbonyl to the nicotinamide ring of NADPH (resulting in the (S)-alcohol product), were considered.
